Skip to Content

MYLAN TM 20 MYLAN TM 20 (Temozolomide 20 mg)

Pill with imprint MYLAN TM 20 MYLAN TM 20 is Yellow & White, Capsule-shape and has been identified as Temozolomide 20 mg. It is supplied by Mylan Pharmaceuticals Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma; melanoma, metastatic and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN TM 20 MYLAN TM 20

Temozolomide

Imprint:
MYLAN TM 20 MYLAN TM 20
Strength:
20 mg
Color:
Yellow & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Alkylating agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-5261

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide